Olive, 2011 - Google Patents
Preparation of near-infrared-labeled targeted contrast agents for clinical translationOlive, 2011
- Document ID
- 490867786849906158
- Author
- Olive D
- Publication year
- Publication venue
- Medical Imaging 2011: Biomedical Applications in Molecular, Structural, and Functional Imaging
External Links
Snippet
Targeted fluorophore-labeled contrast agents are moving toward translation to human surgical use. To prepare for future clinical use, we examined the performance of potential ligands targeting the epidermal growth factor receptor, α5β3 integrins, and GLUT …
- 239000002872 contrast media 0 title abstract description 8
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cai et al. | Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging | |
| Capozza et al. | Photoacoustic imaging of integrin-overexpressing tumors using a novel ICG-based contrast agent in mice | |
| US12133900B2 (en) | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | |
| Zhou et al. | Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice | |
| CN104955484B (en) | Prostate-specific antigen medicament and its application method for prostate cancer imaging | |
| ES2828954T3 (en) | UPAR Site-Specific Peptide for Use in Perioperative Optical Imaging of Invasive Cancer | |
| Liu et al. | Croconaine-based nanoparticles enable efficient optoacoustic imaging of murine brain tumors | |
| Yang et al. | Mapping sentinel lymph node metastasis by dual-probe optical imaging | |
| CN108495655A (en) | For tissue division for example for visual imaging system and method in art | |
| Kurbegovic et al. | IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts | |
| CN102014968A (en) | Therapy selection method | |
| CN108623661A (en) | A kind of bispecific peptide molecule probe of targeted pancreatic cancerous swelling oncocyte and application | |
| US9415122B2 (en) | Methods and compositions for the detection of cancer cells | |
| Abraham et al. | Aptamer-targeted calcium phosphosilicate nanoparticles for effective imaging of pancreatic and prostate cancer | |
| CN113209315A (en) | Polypeptide probe for targeting tumor and application | |
| Li et al. | Near‐Infrared Organic Room Temperature Phosphorescent Probes Targeting Fibroblast Activation Protein for Surgical Navigation of Liver Cancer | |
| Kovar et al. | Purification method directly influences effectiveness of an epidermal growth factor-coupled targeting agent for noninvasive tumor detection in mice | |
| Wu et al. | Multi-modal imaging for uptake of peptide ligand specific for CD44 by hepatocellular carcinoma | |
| Olive | Preparation of near-infrared-labeled targeted contrast agents for clinical translation | |
| US20210138090A1 (en) | uPAR targeting peptide for use in peroperative optical imaging of invasive cancer | |
| CN114555623B (en) | Urokinase plasminogen activator receptor targeting peptides | |
| KR102611306B1 (en) | Albumin-sugar chain complex | |
| KR20240066128A (en) | Methods and agents for detection and treatment of cancer | |
| US11708393B2 (en) | Targeted non-invasive imaging probes of EGFR expressing cells | |
| TW202014517A (en) | Peptides and their use |